OsavampatorOsavampator (developmental code names TAK-653 and NBI-1065845) is an experimental drug being investigated as a treatment for treatment-resistant depression. It is being developed by Neurocrine Biosciences and Takeda Pharmaceuticals (Millennium Pharmaceuticals, Inc.). Read from the Drugbox of the Wikipedia article Osavampator, revision 1370307035.

Property

Value

Formula

C19H23N3O3S, 373.48 g/mol

Elimination half-life

40.45 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.